OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer
Limeng Wu, Wenjie Liu, Yaoguang Huang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114701-114701
Closed Access | Times Cited: 7
Limeng Wu, Wenjie Liu, Yaoguang Huang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114701-114701
Closed Access | Times Cited: 7
Showing 7 citing articles:
Design, synthesis and biological evaluation of dual CDK9/PARP inhibitors for the treatment of cancer
Jindi Huang, Ya He, Sumeng Chen, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117367-117367
Closed Access | Times Cited: 1
Jindi Huang, Ya He, Sumeng Chen, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117367-117367
Closed Access | Times Cited: 1
Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications
Yuming Zhang, Lianhai Shan, Wentao Tang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5185-5215
Closed Access | Times Cited: 12
Yuming Zhang, Lianhai Shan, Wentao Tang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5185-5215
Closed Access | Times Cited: 12
Structure-Guided Discovery of Novel N4-(Substituted Thiazol-2-yl)-N2-(4-Substituted phenyl)pyrimidine-2,4-Diamines as Potent CDK2 and CDK9 Dual Inhibitors with High Oral Bioavailability
Bei Zhang, Yanhong Li, Yukang Lin, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Bei Zhang, Yanhong Li, Yukang Lin, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Discovery and evaluation of novel Benzohydroxamic acid-indole derivatives as dual inhibitors of ADAM17 and HDAC2 with antitumor activity
Xiaoxuan Song, Xin Tong, Kaisi Yang, et al.
Bioorganic Chemistry (2025), pp. 108308-108308
Closed Access
Xiaoxuan Song, Xin Tong, Kaisi Yang, et al.
Bioorganic Chemistry (2025), pp. 108308-108308
Closed Access
Azaindole derivatives as potential kinase inhibitors and their SARs elucidation
Guoqing Fang, Hongjuan Chen, Zhiyun Cheng, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115621-115621
Closed Access | Times Cited: 10
Guoqing Fang, Hongjuan Chen, Zhiyun Cheng, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115621-115621
Closed Access | Times Cited: 10
In-silico investigations of novel tacrine derivatives potency against Alzheimer's disease
Mohamed El fadili, Mohammed Er-rajy, Mohnad Abdalla, et al.
Scientific African (2023) Vol. 23, pp. e02048-e02048
Open Access | Times Cited: 6
Mohamed El fadili, Mohammed Er-rajy, Mohnad Abdalla, et al.
Scientific African (2023) Vol. 23, pp. e02048-e02048
Open Access | Times Cited: 6
Targeting Cyclin-Dependent Kinases: From Pocket Specificity to Drug Selectivity
Yaoguang Huang, Wenwu Liu, Changhao Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116547-116547
Closed Access | Times Cited: 1
Yaoguang Huang, Wenwu Liu, Changhao Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116547-116547
Closed Access | Times Cited: 1
